Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01550796 · ClinicalTrials.gov registry record · Phase 2
Treatment of Chronic Bothersome Tinnitus Using Cognitive Training and D-cycloserine
A Phase 2 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 37
- Enrollment target
NCT01550796 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 37 participants.
The verdict
NCT01550796, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if a medication along with a computer program designed to improve memory and other mental processes can help people like yourself with tinnitus. The medication that will be investigated, d-cycloserine, was developed as an antibiotic. However, more recently, research in other studies has shown that this medication may enhance learning and memory. The investigators would like to determine if computer programs designed to improve memory and attention are enhanced by this medication. In addition, the investigators hope to learn if the use of these programs can help participants with their tinnitus as well as their ability to remember and focus. All research participants will receive therapy with a computer-based program designed to improve memory and attention. Half of participants will also receive d-cycloserine while the other half of participants will receive placebo. The placebo is a sugar pill without active medication.
Interventions
- BEHAVIORAL Cognitive Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01550796
The ClinicalTrials.gov registry entry for NCT01550796 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Training is the first listed.
NCT01550796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01550796 about?
NCT01550796 is a clinical study titled "Treatment of Chronic Bothersome Tinnitus Using Cognitive Training and D-cycloserine". The purpose of this research study is to determine if a medication along with a computer program designed to improve memory and other mental processes can help people like yourself with tinnitus. The medication that will be investigated, d-cycloserine, was developed as an antibiotic. However, more r...
What is the current status of trial NCT01550796?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2012-01. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01550796?
The interventions under investigation include: Cognitive Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01550796?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.